NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19/03/2026
Voltar para busca
Dado oficial do USPTO
INTRAVACC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
20/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 41, 42
Data de depósito
15/01/2014
Data de registro
27/10/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/03/2026
Última transação
20/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
MA Bilthoven, NL
Examinador
MITTLER, KEVIN A
Localização atual
Historical data usage
Titulares e representantes
Titulares
Intravacc B.V.
Ministerie van Volksgezondheid, Welzijn en Sport
Ministerie van Volksgezondheid,; Welzijn en Sport
Representantes
Jeffrey H. Greger STUDEBAKER BRACKETT PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products and preparations for preventiontreatment and immune therapy and combinations of preventiontreatment and immune therapy of infectious diseases and allergic diseasesas well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for preventiontreatment and immune therapy and combinations of preventiontreatment and immune therapy of infectious diseasesallergic diseases and cancer; bacterial and viral vaccinessyntheticrecombinantpeptideproteinRNA-DNA- and therapeutic vaccines
Classe 10
Cups for dispensing medicine; Injection needles for the administration of vaccines and medicines; Injection instruments without needles for the administration of vaccines and medicines
Classe 41
Publication of medical texts and journalsmagazines and articles in the field of cancerinfectious diseases and allergic diseases and immune therapy of diseasesbacterial and viral vaccinessynthetic and therapeutic vaccines; educational servicesproviding training and seminars in the field of vaccines and medicines; organizing educational and informative meetings and conferences in the field of vaccines and medicines ; training in use and administering of vaccines and medicines
Classe 42
Biologicalclinical and medical research in the field of bacterial and viral vaccines and bacterial and viral vaccine technology as well as therapeutic vaccines against allergic diseases and cancer and related vaccine technology; biologicalclinical and medical research and development in the field of synthetic and therapeutic vaccines and synthetic and therapeutic vaccine technology; clinical and preclinical research in the field of immunologythe safety and immunogenicity of candidate vaccine in humans; testing of vaccines and medicines; research in the field of new and existing vaccines and medicines; testing of vaccines and medicines; services of a scientific laboratory; conducting clinical trials and testing; scientific research for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
19/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/02/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/11/2025
ES71
TEAS SECTION 71 RECEIVED
20/10/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
28/10/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/08/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
16/05/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/04/2023
INPC
INVALIDATION PROCESSED
03/04/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/02/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/06/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
09/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/06/2022
ES71
TEAS SECTION 71 RECEIVED
27/10/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
26/03/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/10/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/11/2016
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/06/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
02/06/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/01/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
27/10/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2015
PUBO
PUBLISHED FOR OPPOSITION
11/08/2015
GPNX
NOTIFICATION PROCESSED BY IB
07/08/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/07/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/07/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/07/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/06/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/06/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/02/2015
GNFR
FINAL REFUSAL E-MAILED
16/02/2015
CNFR
FINAL REFUSAL WRITTEN
16/02/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/01/2015
ALIE
ASSIGNED TO LIE
07/01/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/12/2014
RFNT
REFUSAL PROCESSED BY IB
22/08/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2014
RFRR
REFUSAL PROCESSED BY MPU
05/08/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/08/2014
MAFR
APPLICATION FILING RECEIPT MAILED
05/08/2014
CNRT
NON-FINAL ACTION WRITTEN
04/08/2014
DOCK
ASSIGNED TO EXAMINER
30/07/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/07/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/07/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INTRAVACC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.